Vietnamese health tech firm develops AI model for TB diagnosis, screening
VinBrain, an AI healthcare software developer in Vietnam, recently came up with an AI model for the diagnosis and screening of tuberculosis.The Vingroup-backed company...
DarioHealth touts research on digital therapeutics for diabetes patients
DarioHealth (NSDQ:DRIO) announced today that recently published research supports its digital therapeutic platform for type 2 diabetes.New York-based DarioHealth published a new study through a...
Life Spine Gains FDA 510(k) Clearance for PROLIFT Lateral HELO Fixation
Life Spine received FDA 510(k) clearance to market the PROLIFT® Lateral HELO Fixation System. PROLIFT Lateral HELO offers a patient-matched solution that is designed to...
PixCell Medical Announces Acquisition by Soulbrain Holdings
Transaction Underscores PixCell's Leading Position in Disruptive Point-of-Care Testing Technology. PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired...
Ceribell Announces Completion Of $53 Million Series C Financing
Proceeds will be used to expand commercialization of the Ceribell Rapid Response EEG and support pipeline product development to drive future clinical applications.Ceribell, Inc.,...
InBrain raises nearly $17M for graphene-based neuromod system
InBrain Neuroelectronics today announced $16.8 million in Series A funding for its neuroelectronic system designed to treat epilepsy and Parkinson’s disease.The investment in the Barcelona-based...
SeaSpine to acquire 7D Surgical for $110m
Market-Leading Radiation-Free Navigational System Expected to Accelerate Near-Term Revenue GrowthPositions SeaSpine to Address Full Patient Continuum of Care and Expand Presence Beyond Operating RoomHosting...
Smith+Nephew’s ALLEVYN™ LIFE Foam Dressings halved change frequency, significantly reduced cost and improved treatment satisfaction in real-world study
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a real-world study from Spain that showed how a...
Corvista advancing heart disease tech with $65M series C
Corvista Health Inc. has raised $65 million in a series C equity financing led by Ambix Life Science Fund I LP. The new funds are...
